| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/27/2007 | US7300755 Methods for haplotyping genomic DNA |
| 11/27/2007 | US7300754 Identifying sequence variation in lipid metabolic pathway for use in diagnosis, prevention and treatment of cardiovascular and lipid metabolism disorders |
| 11/27/2007 | US7300753 immunoglobulin which binds phosphorylated ubiquitin fusion degradation protein 1 (UFD1) for use in diagnosis, prevention and treatment of cardiovascular and cell proliferative disorders |
| 11/27/2007 | US7300752 Compositions and methods for determining canine gender |
| 11/27/2007 | US7300751 Method for identification of genetic markers |
| 11/27/2007 | US7300749 Molecules of the pyrin domain protein family and uses thereof |
| 11/27/2007 | US7300658 For use in vaccines |
| 11/27/2007 | CA2353792C Mutants of rna polymerases with increased stability |
| 11/27/2007 | CA2217325C Nucleic acid detection and amplification by chemical linkage of oligonucleotides |
| 11/27/2007 | CA2157391C Human liver epithelial cell lines |
| 11/27/2007 | CA2100616C Receptor identification method |
| 11/22/2007 | WO2007134327A2 Neutralizing antibodies to influenza viruses |
| 11/22/2007 | WO2007134320A2 Multi-configurable, scalable, redundant battery module with multiple fault tolerance |
| 11/22/2007 | WO2007134318A2 Relative floorplanning for improved integrated circuit design |
| 11/22/2007 | WO2007134285A2 π-CONJUGATED HEAVY-METAL POLYMERS PARTICULARLY SUITED TO HYDROPONIC APPLICATIONS |
| 11/22/2007 | WO2007134261A2 System and method for natural language processing in a peer-to-peer hybrid communications network |
| 11/22/2007 | WO2007134257A2 Apparatus and method for a combination of ablative and nonablative dermatological treatment |
| 11/22/2007 | WO2007134252A1 Method of protein extraction from cells |
| 11/22/2007 | WO2007134210A2 Methods and compositions for the diagnosis and treatment of cancer |
| 11/22/2007 | WO2007134192A2 Extruded filament for microscopic tagging system |
| 11/22/2007 | WO2007134162A2 Involvement of a novel nuclear-encoded mitochondrial poly(a) polymerase papd1 in extreme obesity-related phenotypes in mammals |
| 11/22/2007 | WO2007134132A2 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 11/22/2007 | WO2007134121A2 Manganese superoxide dismutase val16ala polymorphism predicts resistance to doxorubicin cancer therapy |
| 11/22/2007 | WO2007134098A1 Nonseparation assay methods |
| 11/22/2007 | WO2007133992A2 System and method for reducing driving risk with hindsight |
| 11/22/2007 | WO2007133991A2 System and method for reducing driving risk with insight |
| 11/22/2007 | WO2007133988A1 Nonseparation assay methods |
| 11/22/2007 | WO2007133986A2 System and method for multi-event capture |
| 11/22/2007 | WO2007133985A2 Abnormal output detection system for a biosensor |
| 11/22/2007 | WO2007133982A2 Multi-axis control of a device based on the wireless tracking location of a target device |
| 11/22/2007 | WO2007133971A2 Method and system for processing music on a computer device |
| 11/22/2007 | WO2007133969A2 Sharing of digital media on a network |
| 11/22/2007 | WO2007133968A2 Calculation of quality of wlan access point characterization for use in a wlan positioning system |
| 11/22/2007 | WO2007133957A1 Biomarkers for mesothelioma: apoc1 and apoa2 |
| 11/22/2007 | WO2007133855A2 Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
| 11/22/2007 | WO2007133740A1 Method for identification of novel physical linkage of genomic sequences |
| 11/22/2007 | WO2007133732A2 Dna recombination junction detection |
| 11/22/2007 | WO2007133725A1 Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma |
| 11/22/2007 | WO2007133703A2 Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
| 11/22/2007 | WO2007133591A2 Media package |
| 11/22/2007 | WO2007133590A2 Systems for and methods of characterizing reactions |
| 11/22/2007 | WO2007133586A2 Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets |
| 11/22/2007 | WO2007133075A2 Igf2 marker assisted selection for porcine reproductive traits |
| 11/22/2007 | WO2007132883A1 Method and kit for identifying hepatic cancer, determining the disease stage or estimating the prognosis |
| 11/22/2007 | WO2007132864A1 Method for detection of cancer, and kit for detection of cancer |
| 11/22/2007 | WO2007132844A1 Method for detecting disease-related marker using gastric mucosal lavage fluid |
| 11/22/2007 | WO2007132789A1 Method for production of cleistogamous rice and method for selection of cleistogamous rice |
| 11/22/2007 | WO2007132760A1 Method for detecting or quantifying wheat endogenous dna and method for determining contamination rate of genetically modified wheat in test sample |
| 11/22/2007 | WO2007132589A1 Primer set for detection of dekkera yeast or brettanomyces yeast |
| 11/22/2007 | WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 11/22/2007 | WO2007132226A1 Cholesterol sensor |
| 11/22/2007 | WO2007132223A1 Hdl cholesterol sensor using selective surfactant |
| 11/22/2007 | WO2007132222A1 Hdl cholesterol sensor using selective surfactant |
| 11/22/2007 | WO2007132167A2 Novel fetal markers for prenatal diagnosis and monitoring |
| 11/22/2007 | WO2007132166A2 New fetal methylation markers |
| 11/22/2007 | WO2007132156A2 Materials and methods relating to cancer diagnosis, prognosis and treatment based on the determination of novel molecular markers in tumors |
| 11/22/2007 | WO2007132120A2 Procedure and methods for detecting alzheimer's disease |
| 11/22/2007 | WO2007132002A1 Identification and quantification of a plurality of biological (micro)organisms or their components |
| 11/22/2007 | WO2007132001A1 Design of capture molecules for the detection of amplicons with high sensitivity |
| 11/22/2007 | WO2007131999A1 Lid for pcr vessel comprising probes permitting pcr amplification and detection of the pcr product by hybridisation without opening the pcr vessel |
| 11/22/2007 | WO2007131995A1 Reaction chamber for real time pcr comprising capture probes and permitting detection of the pcr product by hybridisation without opening the pcr vessel |
| 11/22/2007 | WO2007131776A1 SPECIES-INDEPENDENT DNA FINGERPRINT ANALYSIS WITH PRIMERS DERIVED FROM THE NotI IDENTIFICATION SEQUENCE |
| 11/22/2007 | WO2007131696A1 Determination of changes in concentration |
| 11/22/2007 | WO2007131366A1 Iap bir domain binding compounds |
| 11/22/2007 | WO2007131354A1 Methods for detection of target on responsive polymeric biochips |
| 11/22/2007 | WO2007131345A1 Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity |
| 11/22/2007 | WO2007131255A1 Electronic biosensor arrangement |
| 11/22/2007 | WO2007112702A3 Pharmaceutical composition containing the nmb0938 protein |
| 11/22/2007 | WO2007106899A3 System and method for detection of mutations in jak2 polynucleotides |
| 11/22/2007 | WO2007106575A3 Automatable artificial immune system (ais) |
| 11/22/2007 | WO2007101094A9 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome |
| 11/22/2007 | WO2007100919A8 Markers for addiction |
| 11/22/2007 | WO2007100748A3 Protein separation and analysis |
| 11/22/2007 | WO2007096830A3 External cell control quantitative assay |
| 11/22/2007 | WO2007087439A3 Method and apparatus for determining level of microorganisms using bacteriophage |
| 11/22/2007 | WO2007085882A3 Method for the simultaneous detection of mutations occurring in related genomes, exploiting mobility variations in 2-d electrophoresis of dna duplexes undergoing differential helix-coil transition in a denaturing gradient |
| 11/22/2007 | WO2007081896A3 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 11/22/2007 | WO2007065697B1 Selection marker system and method for screening a choline tolerant plant cell |
| 11/22/2007 | WO2007065035A3 Synthesis of error-minimized nucleic acid molecules |
| 11/22/2007 | WO2007062160A3 Methods and compositions for sequencing a nucleic acid |
| 11/22/2007 | WO2007058977A3 Kifs as modifiers of the rho pathway and methods of use |
| 11/22/2007 | WO2007038792A3 Individualized cancer treatments |
| 11/22/2007 | WO2007019492A3 Methods for detection of a nucleic acid by sequential amplification |
| 11/22/2007 | WO2007011322A3 Methods and compositions for diagnosis of alzheimer's disease and other neurodegenerative disorders |
| 11/22/2007 | WO2007002735A3 Bovine abcg2 gene missense mutations and uses thereof |
| 11/22/2007 | WO2007002384A3 Methods for genotype screening of a strain disposed on an adsorbent carrier |
| 11/22/2007 | WO2007002383A3 Methods for forensic and congenic screening |
| 11/22/2007 | WO2006133208A3 Hydrodynamic capture and release mechanisms for particle manipulation |
| 11/22/2007 | WO2006130347A3 Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
| 11/22/2007 | WO2006130128A3 Methods of identifying anti-inflammatory macrolides |
| 11/22/2007 | WO2006121423A3 Nucleic acid melting analysis with saturation dyes |
| 11/22/2007 | WO2006096527A3 Nucleic acids and proteins and methods for making and using them |
| 11/22/2007 | WO2006092669A3 Methods of detecting a phenotype of a polymorphic protein |
| 11/22/2007 | WO2006086777A3 Methods and compositions for detecting a drug resistant egfr mutant |
| 11/22/2007 | WO2006081324A3 Dnd purification and analysis on nanoengineered surfaces |
| 11/22/2007 | WO2006080021A3 Multistep reaction lateral flow capillary device |
| 11/22/2007 | WO2006025863A3 Simultaneous detection of metabolic enzyme activity and metabolite levels |
| 11/22/2007 | WO2005122709A3 Purification methods and uses thereof |
| 11/22/2007 | WO2005079279A3 High throughput screening methods for fuel compositions |
| 11/22/2007 | WO2005067667A3 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |